Laura Bagby (6 Degrees Communications Corporation)

Bagby, Laura (6 Degress Communications 201701)

	Organisation	6 Degrees Communications Corporation
	Product	public relations / investor relations / marcom (services)
	Product 2	LIFE SCIENCES

G1 Therapeutics, Inc.. (1/3/17). "Press Release: G1 Therapeutics to Present at 35th Annual J.P. Morgan Healthcare Conference". Research Triangle Park, NC.

G1 Therapeutics, Inc., a clinical-stage oncology company, announced today that Chief Executive Officer Mark Velleca, MD, PhD, will present a company overview at the 35th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Tuesday, January 10, at 9 a.m. PT at The Westin St. Francis Hotel in San Francisco.

About G1 Therapeutics, Inc.

G1 Therapeutics is a clinical-stage oncology company developing novel, small-molecule therapies that address significant unmet needs in people with cancer. The company is advancing a pipeline of potential best-in-class and first-in-class drug candidates in multiple oncology indications. G1 is privately held and based in Research Triangle Park, NC.

Visit www.g1therapeutics.com for more information.

###

Contact:
Mark Velleca, MD, PhD
G1 Therapeutics
919-213-9838
mvelleca@g1therapeutics.com

Investors:
Robert Uhl
Westwicke Partners
858-356-5932
robert.uhl@westwicke.com

Media:
Laura Bagby
6 Degrees Communications
312-448-8098
lbagby@6degreespr.com